↓ Skip to main content

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison

Overview of attention for article published in Experimental Hematology & Oncology, December 2013
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#44 of 183)
  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison
Published in
Experimental Hematology & Oncology, December 2013
DOI 10.1186/2162-3619-2-32
Pubmed ID
Authors

James Signorovitch, Elyse Swallow, Evan Kantor, Xufang Wang, Judith Klimovsky, Tomas Haas, Beth Devine, Peter Metrakos

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Brazil 1 3%
Unknown 35 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 24%
Student > Ph. D. Student 6 16%
Student > Bachelor 4 11%
Other 4 11%
Professor 3 8%
Other 5 14%
Unknown 6 16%
Readers by discipline Count As %
Medicine and Dentistry 18 49%
Biochemistry, Genetics and Molecular Biology 4 11%
Economics, Econometrics and Finance 4 11%
Computer Science 1 3%
Psychology 1 3%
Other 1 3%
Unknown 8 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2020.
All research outputs
#5,862,176
of 17,977,824 outputs
Outputs from Experimental Hematology & Oncology
#44
of 183 outputs
Outputs of similar age
#166,607
of 410,017 outputs
Outputs of similar age from Experimental Hematology & Oncology
#7
of 25 outputs
Altmetric has tracked 17,977,824 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 183 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 410,017 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.